Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crocs, Inc. (CROX) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Crocs, Inc.Trade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Crocs, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Crocs, Inc. trades at $131.94 (market cap $6.31B), while State Street SPDR S&P Biotech ETF trades at $158.55. Which is the better fit depends on your goals.

CROXXBI
Market Cap
$6.31B
Sector
Consumer StaplesBroad Market / Factor
52-Week High
$141.19$164.28
52-Week Low
$73.39$86.92
Enterprise Value
$7.83B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crocs, Inc.

Crocs (CROX) trades at $138.19, up 1.15% today, near its 52-week high. The stock shows bullish technical signals with strong earnings beats in recent quarters, including Q2 2026 EPS of $4.55 versus $4.35 expected. Revenue trends are stable around $4B annually, though 2025 net income was negative due to high taxes. Analysts maintain a buy-heavy consensus with a $140.43 price target.

Outlook is positive with robust profitability margins and valuation support, but risks include tax scrutiny from recent Malta office news and HEYDUDE brand weakness. The stock offers growth potential if execution improves, yet investors face volatility from guidance misses and competitive pressures.

State Street SPDR S&P Biotech ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Crocs, Inc.

Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.

Read more on CROX

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI